Member Info for notaflipper

Not sure if you were being sarcastic but for benefit of all FY Results on 26th, so Friday.
Look at IATA warning on Q4 results where 3rd lockdown has had worse than Q3 predicted impact.

@radhatgeorge The Total Voting rights for the Company was 1,992,032,634 issued shares in circulation on the 28th Feb 2020. The shares in circulation confirmed on the 29th Jan 2021 RNS confirmed 4,971,476,010. So in the last year there has been 2,979,443,376 New Shares (representing 100% of the total number of New Shares issued) following 2 October 2020 statement. Share price on the 24th Feb was 375p I believe.
Most PIs don't look at the shares in issue to give them a weighted average when looking at historical share prices. So with a doubling of the shares in issue the reality is that most of the recovery in the SP has already taken place. Perhaps 10p more max but difficult to see 200p being broken until all quarantine measures rolled out in EU and US. With the grim 500k US death milestones reached this week in the US it has to be expected that US travel will not recover till Q2 '22. So with the pension shortfall to clear up you are looking at a long haul back to past 'unweighted' sp levels.

Just keep on pumping.
Only will ever go up.
P.S. Citadel has increased their short again.

That or overbought on rose tinted lockdown release glasses. Think Trading Update coming up will give some people a dose of reality here. Latest FU gives you some idea of the reduced income expected to help to pay pension short fall.

Been a long wait for some but with results next week the rise could be pointing to positive newsflow. Expecting 50p at some point next week. Hopefully will not take profit too soon as think this will have some legs

I appreciate that the there is still a debt hurdle to fully overcome, and profitability confirmation awaiting in early March. That said there have been over £2bn in contract awards since Dec plus the sale of the ESS as well as shorts closing and wider market recovery. The sp response here, since mid-Dec, has been a tight lateral trading range irrespective of news. I have seen this a few times before. Last time was with PURP results which spiked following a similar trading range. I am hoping for a 60p target in the next month here. Hopefully after the long wait I will have the patience not to sell too quick.

Shorts unchanged since 4 Feb 2021 with Sandbar Asset Management LLP still holding a 0.62% short. This is soon to rerate up to 60p imo in next 1month. Just need to be patient and not sell to quick once the MM brakes are finally off. Clear that MMs been holding this pegged for a few months now.

£14.45k buy and sp doesn't move despite only 4 trades. Same pattern week on week. It is enough to make one scream. With limited Free Float how long can this go on? Any ideas on what the MMs are waiting for?

The tight trading range since mid-Dec is what gets me. I accept we had a 2-week wobbly in January where it went down to 33p but aside from then the sp range has been pretty level irrespective of the news, contract wins, asset sales, holdings RNS...nothing seems to shake it. I have been in a few shares before TU/Results (last one was PURP) where the same pattern has happened and everyone tears there hair out, looks for better short term returns elsewhere and so on. All the while MMs accumulate and the next thing you know it has gone up by 30% in less than a week. Unfortunately most holders sell too quick once the release does come.
Still expecting this to come good though I do hope we do not have to wait all the way till the 5th March in this holding pattern.

Contrast becomes more stark when you think CINE has 5.81% shorts whereas CPI only has 0.62%.
Expecting quite a few good weeks here till Results as seems to be coming together. Few similar potential value recovery plays still out there.
Will come good. GLA

They originally paid £10m for the business and thereafter 3 annual payments of £9.4m per year when it took it over in 2013. Surely must have a target price of £150m to £200m+ on revenues of £47.6m?

Seems to be following the script of recovering , in line with wider market, to coincide with lockdown restriction news. Bit amazed that potential lockdown extensions have not hampered other stocks (e.g., CINE, IAG). This should increase in small gains all the way till Results in early March. That seems to be the key news for take-off. I suspect the (frustrating) holding pattern that we have had since mid-Dec means that there has been some background accumulation, as evidenced by Schroder's RNS, and that the news in March should come good. Good luck all!

I had hoped that the Trading Update in Jan would start the re-rate in similar pace that we saw last year. Forecast was better than in Half Year results, with a recovering market post Covid lock-down coming, so performance has been a bit disappointing.
Been holding this for 4 months now and not sure how much longer this will trade sideways. Hopefully it will not take until Finals which will be in a few months. Any ideas?

You can try and get a rise from me but it is just plain to see you are trying to distract from your own ignorance and lack of knowledge. My own P/L on my trading ledger last year was close to £50k in profit (which can be verified by posts on other BBs. However as before it doesn't matter as what happens on this stock and BB does. I am afraid your confidence have proved costly to many around you. I wish you well in your investment. For future reference you are filtered alongside any future suspected aliases.

We are not the same. You are a thug without a brain.

Still waiting and can play this game until Oct...
You have spent best part of 1 year naysayers so let us give you the opportunity to embellish , which as Holders we all hope for. Here is some ideas on what you talk upon to protect and enhance your investment. Given the (nearly 20%) forecast downgrade from £24.9m to potentially £18m today please could you assure troubled, and according to you whining investors, on the resulting operational cash situation with the emphasis given to break-even. This as you will recall, from the presentations, last year mentioned as an aspiration of the BoD. You will be aware of course that the cash used by operations has a run rate of £1.2m in H1 and net cash stood at £11.9m in Sep. What will be the financial headroom given the reduction in Sales forecast which would mean that a placing (for cash for operations vs acquisitive growth) will be unnecessary as this would obviously factor in broker forecasts. There could be a potential further drag with potential earn-outs to Coastal Genomic of up to £1.5m in equity and £4.8m in cash due. I take it that an obvious silver lining is that is now unlikely? Turning back to the diagnostic side what will be impact of test and lab accreditation and product development given today's forecast?

@Quickdraw: Market capitalisation is £89m

Try harder. This is your investment. You have told everyone to FO who raised concerns till now. Here you go, forecasts came down today. Now use the big brain and come back with some financial analysis or diagnostic / scientific USP offering to ramp up your investment. We believe in you Cooper. We await your analysis.

There you go same hostility and aggression . Telling people to FO. Christ come up with some scientific analysis, financial forecast as opposed to thuggery. Christ what a moron.

So obvious. Use another phone so your same typos don't reappear

Stop posting to yourself